Proteolytic and nonproteolytic activation mechanisms result in conformationally and functionally different forms of coagulation factor XIII A
Open Access
- 28 August 2019
- journal article
- research article
- Published by Wiley in The FEBS Journal
- Vol. 287 (3) , 452-464
Abstract
Factor XIIIA (FXIIIA) is a transglutaminase that cross‐links intra‐ and extracellular protein substrates. FXIIIA is expressed as an inactive zymogen, and during blood coagulation, it is activated by removal of an activation peptide by the protease thrombin. No such proteolytic FXIIIA activation is known to occur in other tissues or the intracellular form of FXIIIA. For those locations, FXIIIA is assumed instead to undergo activation by Ca2+ ions. Previously, we demonstrated a monomeric state for active FXIIIA. Current analytical ultracentrifugation and kinetic experiments revealed that thrombin‐activated FXIIIA has a higher conformational flexibility and a stronger affinity toward glutamine substrate than does nonproteolytically activated FXIIIA. The proteolytic activation of FXIIIA was further investigated in a context of fibrin clotting. In a series of fibrin cross‐linking assays and scanning electron microscopy studies of plasma clots, the activation rates of FXIIIA V34X variants were correlated with the extent of fibrin cross‐linking and incorporation of nonfibrous protein into the clot. Overall, the results suggest conformational and functional differences between active FXIIIA forms, thus expanding the understanding of FXIIIA function. Those differences may serve as a basis for developing therapeutic strategies to target FXIIIA in different physiological environments.Enzymes: Factor XIIIA ( EC 2.3.2.13)Keywords
Funding Information
- British Heart Foundation (PG/08/052/25172, RG/18/11/34036)
- National Institutes of Health (R01 CA211098, R15 HL120068)
This publication has 56 references indexed in Scilit:
- Role of calcium in the conformational dynamics of factor XIII activation examined by hydrogen–deuterium exchange coupled with MALDI-TOF MSArchives of Biochemistry and Biophysics, 2011
- Plasma Membrane Factor XIIIA Transglutaminase Activity Regulates Osteoblast Matrix Secretion and Deposition by Affecting Microtubule DynamicsPLOS ONE, 2011
- Factor XIII: novel structural and functional aspectsJournal of Thrombosis and Haemostasis, 2011
- Factor XIII transglutaminase supports hematogenous tumor cell metastasis through a mechanism dependent on natural killer cell functionJournal of Thrombosis and Haemostasis, 2008
- Extracellular calcium as an integrator of tissue functionThe International Journal of Biochemistry & Cell Biology, 2008
- Perturbations in Factor XIII Resulting from Activation and Inhibition Examined by Solution Based Methods and Detected by MALDI-TOF MSBiochemistry, 2007
- Protein production by auto-induction in high-density shaking culturesProtein Expression and Purification, 2005
- .alpha.-Thrombin-catalyzed activation of human platelet factor XIII: relationship between proteolysis and factor XIIIa activityBiochemistry, 1989
- Mechanism and BASIS for Specificity of Transglutaminase‐Catalyzed ε‐(γ‐Glutamyl) Lysine Bond Formation1983
- Kinetics of transamidating enzymes. Production of thiol in the reactions of thiol esters with fibrinoligaseBiochemistry, 1974